Product Images Amlodipine And Olmesartan Medoxomil
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 10 images provide visual information about the product associated with Amlodipine And Olmesartan Medoxomil NDC 42571-238 by Micro Labs Limited, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
This is a medication that contains a combination of 13.9 mg amlodipine besylate and 20mg olmesartan medoxomil per tablet. Each tablet is equivalent to 10mg of amlodipine according to USP standards. The dosage and usage instructions are detailed in the package insert. The tablets should be stored at 25°C (77°F) with permitted excursions to 15° to 30°C (59° to 86°F). The manufacturer of the tablets is Micro Labs USA Inc., and they come in packs of 30 tablets.*
Each tablet contains 6.9 mg of amlodipine besylate equivalent to 5 mg of amlodipine and 40 mg of olmesartan medoxomil, USP. The dosage and usage details can be found in the package insert. Store between 25°C to 30°C. The tablets are manufactured by Micro Labs Limited and a 2D matrix code is present. The tablets are available in a pack of 30. The remaining text is a combination of codes and references to manufacturing details.*
Each tablet contains 13.9 mg of amlodipine besylate, equivalent to 10 mg of amlodipine and 40 mg of olmesartan medoxomil. It is manufactured by Micro Labs USA Inc. for Rx Only. Dosage and use information can be found in the package insert. The tablets should be stored at 25°C (77°F) with permitted excursions to 15° to 30°C (59° to 86°F). The remaining text is not readable.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.